CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Relevance of quantitative HBsAg (qHBsAg) during long-term treatment of chronic hepatitis B with nucleos(t)ide analogues (NUCs)
DOI 10.1055/s-0030-1269706
Bibliografische Angaben
Nachweis in CareLit
Autor:innenJ Jaroszewicz, H Ho, K Deterding, A Markova, K Wursthorn, HL Tillmann, S Schulz, TC Bock, MP Manns, H Wedemeyer, M Cornberg
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe01/2011
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
qHBsAg has been show to predict response to interferon alfa but may also be useful to dissect the phase of HBV-infection. The aim of this study was to analyze if qHBsAg is useful for the prediction of HBsAg loss during NUC therapy. HBsAg was quantified in 126 patients with chronic HBV-infection. 95 patients received therapy with NUCs and were followed for 6–107 months. 31 patients not receiving therapy were observed…
Zitieren
Zitierempfehlung
J Jaroszewicz, H Ho, K Deterding, A Markova, K Wursthorn, HL Tillmann, S Schulz, TC Bock, MP Manns, H Wedemeyer, M Cornberg (2011) Relevance of quantitative HBsAg (qHBsAg) during long-term treatment of chronic hepatitis B with nucleos(t)ide analogues (NUCs). Zeitschrift für Gastroenterologie (01). https://doi.org/10.1055/s-0030-1269706
Mit CareLit weiterarbeiten